Laboratory Test Preparation

• Rapid Test COVID-19 Ag
• SARS-CoV-2 Antigen
• COVID-19 Ag Rapid Diagnostic Test (RDT)
• COVID-19 Ag Rapid Test
• SARS CoV-1 Ag Test

Not applicable

• Used for qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab.
• Used as an aid in the diagnosis of SAR-CoV-2 infection

Rapid immunochromatography

Molecular Diagnostics

• COVID-19 Antigen (Rapid) testing is most useful during the acute phase of the desease when the viral load is high, which is within 5 days after onset of symptoms, however, it is the doctor's prerogative to request when he deems necessary. Note: A doctor's request ismandatory.
• Present a valid ID with picture to Reception and Sample Collectors:

SAMPLE COLLECTION:

1.For walk in patients,sample collection is available by schedule in selected branches. (Please check website for contact details and branches available for collection).

2.For Sample Collectors: Wear proper PPEs and practice safety procedures in handling specimens.

3. If the patient has a lot of mucous in his/her nose, this can interfere with the collection of cells. Patient should use a tissue to gently clean out visible nasal mucous before a swab is taken. Discard tissue used as biohazard waste.

Extraction Tube of COVID-19 Ag Kit

Nasopharyngeal Swab

Not applicable

• Room Temperature (15-30'C) - 2 hours
• Refrigerated Temperature (2-8'C) - Not acceptable
• Freezer Temperature (-20'C or lower) - Not acceptable

          Note:Direct swab samples should be tested immediately after collection.

Room Temperature (15-30'C) - 2 hours

Not acceptable

Not acceptable

• Transport sample to Laboratory ASAP at room temperature

• Exceeded sample stability requirement
• Improper labeled sample
• Improper collection tube used
• Sample other than nasopharygeal swab
• Incorrect volume of buffer used

Daily

6;00 PM

ROUTINE:  4 hours after receipt of sample

STAT:         2 1/2 hours after receipt of sample

Negative result:The presence of onl the control line (C) and no test line (T) within thge result window indicates a negative result.

Comment:A negative test result does not eliminate the possibility of SAR-CoV-2 infection and should be confirmed by aMolecular assay. Consult your doctor.

Positive result:The presence of the test line (T) and the control line (C) within the result window, regradless of which line appears first, indicates a positive result.

Note:The presence of any test line (T), no matter how faint, indicates a positive result.

Comment:Results may be confirmed with aMolecular assay. Consult yur doctor.

Invalid result:If the control line (C) is not visible within the result window after performing the test, the result is considered invalid.

• Positive test results do not rule out co-infections with other pathogens.
• For further information on immune status, additional follow -up testing using other laboratory methods is recommended.
• Test results must be evaluated in conjunction with other clinical date available to the physician.
• This COVI-19 Ag Rapid Test Device is not intended to detect from defective (N=non-infectious) virus during the later stages of viral shedding that might be detected by PCR moleculat tests.

Q:What is COVID-19 Ag Rapid Test?

A:Anin vitrodiagnostics rapid test for qualitative detection of SARS-CoV-2 antigen (Ag) using nasopharyngeal swab as sample.

Q:How does a rapid antigen detection test for COVID-19 work?

A:One type of rapid diagnostic test detects the presence of viral proteins (antigens) expressed by the COVID-19 virus in a sample from the respiratory tract of a person. If the target antigen is present in sufficient concentration in the sample, it will bind to specific anitbodies fixed to a paper strip enclosed in a plastic casing and generate a visually detectable signal, typically within 30 minutes. The antigen(s) detected are expressed only when the virus is actively replicating: therfore, such tests are best used to identify acute or early infection.

Q:What is the sensitivity and specificity of this test?

A:Positive specimens post onset of symptoms or suspected exposure between 0-3 days has a snsitivity of 94.9% and 4-7 days has a sensitivity of 90.1%.Overall sensitivity: 91.4%; Specificity: 99.8%

Q.What is the difference between COVID-19 Antigen and COVID-19 RT-PCT test?

A.: COVID-19 Ag Rapid Test Device detects antigens produced by the virus while COVID-19 RT-PCR test detects the virus RNA.. COVID-19 Antigen RAPID test does not detect defective (non-infectious) virus during the later shedding that might be detected by RT-PCR molecular tests.

2019-nCoV IgG/IgM Antibody Detection, Corona virus disease, SARS-CoV-2, Flu desease.

• Picornavirus

Coxsackie Antibodies :

• B1

• B2

• B3

• B4

• B5

• B6

Coxsackie B Virus can cause rashes, pharyngitis, meningitis and myocarditis.

Complement Fixation (CF)

Special Test

No patient preparation necessary.

Red or Gold Tube / Steril Container for CSF

3 mL Serum / 3 mL CSF

7 Days

14 Days

30 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Batch Running

Friday 4:00 PM

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Culture does not usually support growth of coxsackie A viruses.

• Rhinovirus

• Echovirus group

• Foot and Mouth Syndrome (kawasaki)

Coxsakie B (1-6) Antibodies

Coxsackie Antibodies B1, B2, B3, B4, B5, B6

Used to aid in the diagnosis of Coxsackie virus infection

Complement fixation (CF)

Special Test

No patient preparation necessary.

Sterile Leak-Proof Container

2 mL CSF

Not Applicable

24 Hours

7 Days

28 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Quantity Not sufficient
• Improperly labeled specimen
• Improperly container used

Batch running

Monday, 12:00 PM

3 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None Specified

Q: How common is coxsackie B virus?

A:Coxsackie B infections are most common in children, but may occur in adults

Q: What are the manifestations for this virus?

A:Clinical manifestations include:

• fever
• aseptic meningitis
• costochondritis
• pharyngitis
• myocarditis
• splenomegaly
• diarrhea
• maculopapular non-pruritic rash

Q: How is Coxsackie B virus transmitted?

A:The Coxsackie B virus gains access to the body through the mouth by the fecal-oral mode of transmission. The virus may also spread through contact with infected mucosal secretions

Q: Is Coxsackie B virus contagious?

A:Coxsackieviruses are very contagious. They can be passed from person to person on unwashed hands and surfaces contaminated by feces. They also can be spread through droplets of fluid sprayed into the air when someone sneezes or coughs.

Not Applicable

Coxsakie B (1-6) Antibodies

Coxsackie Antibodies B1, B2, B3, B4, B5, B6

Used to aid in the diagnosis of Coxsackie virus infection

Complement Fixation (CF)

Special Test

No patient preparation necessary.

Red or Gold Tube

3 mL Serum

Not Applicable

24 Hours

7 Days

15 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Hemolyzed specimen
• Quantity Not sufficient
• Markedly lipemic sample
• Improperly labeled specimen

Batch running

Monday, 12:00 PM

3 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None Specified

Q: How common is coxsackie B virus?

A:Coxsackie B infections are most common in children, but may occur in adults

Q: What are the manifestations for this virus?

A:Clinical manifestations include:

• fever
• aseptic meningitis
• costochondritis
• pharyngitis
• myocarditis
• splenomegaly
• diarrhea
• maculopapular non-pruritic rash

Q: How is Coxsackie B virus transmitted?

A:The Coxsackie B virus gains access to the body through the mouth by the fecal-oral mode of transmission. The virus may also spread through contact with infected mucosal secretions

Q: Is Coxsackie B virus contagious?

A:Coxsackieviruses are very contagious. They can be passed from person to person on unwashed hands and surfaces contaminated by feces. They also can be spread through droplets of fluid sprayed into the air when someone sneezes or coughs.

Not Applicable

• CardioIQ®

• Clopidogrel

Not applicable

• This test detects variants in the CYP2C19 gene leading to altered enzyme activity and may require alternative treatments or altered drug dosage of a drug metabolized by CYP2C19 for optimal therapeutic response.

Allele-Specific Primer Extension • Polymerase Chain Reaction (PCR)

Special Test

No patient preparation necessary.

EDTA or Violet Tube

4 mL EDTA whole blood

Not applicable

8 Days

8 Days

30 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Improperly labeled specimens
• Incorrect collection tube used
• Hemolyzed specimens
• Lipemic specimens
• Quantity not sufficient
• Specimen transported outside the required temperature.

Batch Running

Monday, 12:00 PM

14 days after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None specified

Not applicable

Not applicable

   1. Cystatin - C

   2. Estimated GFR (CKD-EPI)

• Use to calculate for Estimated Glomerular Filtration Rate (e-GFR) which in turn helps Physicians assess how well a person’s kidney is working.Used when a previous test for  kidney function was inconclusive or needs to be confirmed.
• Used for patients who are overweight, elderly, or patients who does not have the average muscle mass/weight (whether higher or lower). Cystatin C-based estimates for GFR are believed to be less influenced by muscle mass or diet than Creatinine-based estimates.

• Cystatin C:Particle-Enhanced Turbidimetric Immunoassay (PETIA)
• e-GFR:calculated based on CKD-EPI CYSTATIN C EQUATION (2012)

Chemistry

No patient preparation required.

Red or Gold tube

1-3 mL Serum

1-3mL Plasma (Li-heparin, Na-heparin, EDTA)

2 Days

7 Days

1 Month

Transport specimen at 2°C – 8 °C (with cold packs).

• Specimens that failed serum index (hemolyzed and lipemic)
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Tuesday and Friday

Monday to Saturday: 6:00 PM

Cystatin C:

• 0~49 Y/O Male: 0.31~0.79 mg/L
• 0~49 Y/O Female: 0.40~0.99 mg/L
• 50~999Y/O  Male: 0.41~0.99 mg/L
• 50~999Y/O  Female: 0.40~0.99 mg/L

Estimated GFR:>60 mL/min/1.73m^2

• Bilirubin, conjugated: 66 mg/dL(1128.6 umol/L)
• Bilirubin, unconjugated: 60 mg/dL (1026 umol/L)
• Hemoglobin: 1000 mg/dL (10 g/L)
• Intralipid: 1000 mg/dL (10 g/L)
• Rheumatoid factor: 500 IU/mL (300 kU/L)

Q: How is it used?

A: A Cystatin C test may be used as an alternative to creatinine and creatinine clearance to screen for and monitor kidney dysfunction in those with known or suspected kidney disease. It is most useful in special cases where creatinine measurement could be misleading. Examples are patients with liver cirrhosis, are very obese, are malnourished, practice a vegetarian diet, have amputated limbs, or have reduced muscle mass (elderly and children). Cystatin C is not affected by body mass or diet, and hence is a more reliable marker of kidney function than creatinine. Measuring cystatin C may also be useful in the early detection of kidney disease when other test results (eGFR, creatinine or urine albumin) may still be normal or borderline and an affected person may have few, if any, symptoms. In this case, the healthcare practitioner may want to confirm if chronic kidney disease is present by measuring cystatin c.

Q: What does the result mean?

A: A high level of cystatin C in the blood corresponds to a decreased glomerular filtration rate (GFR) and hence to kidney dysfunction. Since cystatin C is produced throughout the body at a constant rate and removed and broken down by the kidneys, it should remain at a steady level in the blood if the kidneys are working efficiently and the GFR is normal. Recent studies suggest that increased levels of cystatin C may also indicate an increased risk of heart disease, heart failure, and mortality.

Q: What are the limitations of Cystatin test?

A: Although cystatin C is less variable and less affected by age, body mass, and diet than creatinine in some individuals, it is not a perfect test and can be affected by a number of drugs and other medical conditions. Some studies have reported increased cystatin C levels associated with higher levels of C-reactive protein (CRP) or body mass index (BMI), hyperthyroidism, steroid use, malignant diseases, HIV/AIDS, rheumatic diseases, and certain metabolic conditions such as hyperhomocysteinemia (increased homocysteine). In addition, other studies suggest that cystatin C can be cleared by non-kidney pathways, such as in the gut, and that its levels tend to fluctuate among patients with kidney transplants.

Q: Can Cystatin C be measured in urine samples?

A: No. Unlike creatinine, cystatin C is reabsorbed from the glomerular filtrate and then metabolized in the kidneys. Under normal conditions, cystatin C is not found at detectable levels in the urine.

BUN, Creatinine Clearance, Comprehensive Metabolic Panel, Basic Metabolic Panel, Urinalysis, Urine Protein to Creatinine Ratio, Urine Albumin and Urine Albumin/Creatinine Ratio, Renal Panel, Beta-2 Microglobulin

Taenia

Not Applicable

An infection due to the ingestion of cysterci of the porcine tape worm (Taenia solium) characterized by the development of small cysts in muscle, subcutaneous, eye and brain tissue (40% of cases). The clinical picture is related to the number of cysterci present. Serological analysis gives a positive result in 50% of patients and can be useful for confirmation of a diagnosis proposed on the basis of imaging techniques or histological examination of biopsy material.

Enzyme-immunoassay

Special Test 

No patient preparation necessary.

Red or Gold Tube

3 mL Serum

Not Applicable.

24 Hours 

7 Days 

28 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Hemolyzed specimen
• Quantity Not sufficient
• Improperly labeled specimen
• Markedly lipemic sample

Batch Running

Tuesday and Friday, 12:00 PM

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None specified.

Q: What is Cysticercosis?

A:Cysticercosis is  an infection caused by the larvae of the parasite Taenia solium. This infection occurs after a person swallows tapeworm eggs. The larvae get into tissues such as muscle and brain, and form cysts there (these are called cysticerci). When cysts are found in the brain, the condition is called neurocysticercosis.

Q: What is the relationship between human tapeworm and porcine (pig) cysticercosis?

A:Human get the tapeworm infection after eating raw or undercooked pork contaminated with cysts of T. solium. When swallowed the cysts pass through the stomach and attach to the lining of the small intestine the cysts develop into adult tapeworms over about two months.

Q: Where is the cysticercosis found?

A:Cysticercosis is found worlwide. Infection is found most often in rural areas of developing countries where pigs are allowed to roam freely and eat human feces and where hygiene practices are poor. Cysticercosis is rare in people who live in countries where pigs do not have contact in human feces. People can sometimes get  cysticercosis even if they have never traveled outside the country.

Not Applicable. 

Not applicable

Not applicable

• Cystinuria is an autosomal recessive disease in which dibasic amino acids, including cystine, are excreted in excess.

Liquid Chromatography/Mass Spectrometry (LC/MS)

/ HPLC - High Performance Liquid Chromatography

Special Test

No patient preparation.

Plastic leak proof clean container

50 Ml Random Urine

Not applicable

Not applicable

24 Hours

60 Days

Transport specimen at 2 – 8 °C (with cold packs)

•Quantity not sufficient

• Received room temperature

•Improperly labeled specimen

• Improper urine collection

• with preservatives

Batch Running

Friday, 4:00 PM

14 Days after cut-off (excluding Saturdays, Sundays and Holidays)

Available upon request

None specified.

Not applicable

• Cytology

• Not applicable

• Used to aid in the diagnosis of cancer, but also helps in the diagnosis of certain infectious diseases and other inflammatory conditions
• Used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues.

• Cytospin and Papanicolau Staining

• Histopathology

• Fresh sample must be delivered at once to the laboratory. Refrigerate if delay is anticipated.
• Label with two (2) patient identifiers
• Complete the Histopathology Request form (HPD_F_258) or Histopathology Service Request Form (HPD_F_259)

• Clean, tightly sealed bottle

1. CSF – 1.0 mL
2. Urine cytology – 50.0 mL
3. Other body fluids – 30.0 mL

• Not applicable

• 1 Day

• 7 Days

• Not applicable

• Transport specimens at 2°C to 8°C

• Incomplete information in the Histopathology Request form (HPD_F_258) or Histopathology Service Request Form (HPD_F_259)
• Improperly labeled specimens
• Quantity not sufficient
• Exceeded sample stability requirement.

• Daily

• 7:00 PM

• 3 to 5 days after receipt of specimen (with reading/interpretation)
• 1 day for Metro Manila clients and 2 days for Provincial clients (processing only)
• Note: Additional 2 days may be necessary if specimen needs further evaluation and confirmation by another Pathologist.

• Not applicable

• Not applicable

• Not applicable

• Cytology

Cytogenetics-Philadelphia (KARYOTYPING)

Not Applicable

For fertility work-up

NOTE:Identification of chrmomosome abnormalities in cells obtained from the given sample is limited to those observed on metaphase spreads prepared by routine cytogenetic processing and analysis standards. In addition, this method does not rule out other forms of genetic abnormalities like low level tissue mosaicisms, submicroscopic abnormalities and other molecular mutations that are not detectable given the the limit of resolution of this procedure. 

GTG-Banding

Special Test

• No patient preparation necessary.
• Need Diagnosis
• Doctors Request 
• Please call laboratory prior to extraction. 
• For schedule  (SPECIAL TRIP) 
• Send sample immediately to HPD Del Monte 
• Time of extraction will be 6AM only. (BRANCHES WITHIN METRO MANILA) (specimen should be at Laboratory at exactly 7AM)
• Time of extraction will be 3PM onwards (FOR PROVINCIAL BRANCHES) (specimen should be at Laboratory until 7AM)

Sodium Heparin Tube

 3 Pcs of 4 mL Sodium Heparinized whole blood 

Not Applicable

24 Hours

Not Applicable

Not Applicable

Transport specimen at 15°C ~25 °C (room temperature)

• Improperly labeled specimens
• Clotted specimens
• Over-filled or Under-filled tube
• Quantity not sufficient
• Specimen stored and transported outside the required temperature

Monday to Friday

Monday to Friday, 7:00 AM

4 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Not Applicable

None Specified

Not Applicable

Congenital disorders, Down syndrome

Fibrin Degradation Fragment
Fragment D-dimer

Not Applicable

Used as an aid when deep venous thrombosis and pulmonary embolism is suspected

Sandwich Complex

Serology

Please note the date and time of collection on sample tube and request.

Note: If date and time of collection not indicated we will automatically proceed the test but a comment will be reflected on the result, “No date and time of collection provided”.

Heparin (Green Top)

2mL Heparinized Whole Blood

Not applicable

8 Hours

Unacceptable

Unacceptable

Transport specimen at 15-25°C (room temperature)

• Exceeded sample stability requirement
• In appropriate collection tube (wrong anticoagulant)
• Volume of blood to anticoagulant is not proportioned (Underfilled/Overfilled)
• Clotted samples.
• Improperly labeled specimens
• Quantity not sufficient

Daily

Monday to Saturday
• 6:00 PM


Sunday
• 3:00 PM

ROUTINE
• 3 hours after receipt of specimen/ arrival of messenger
STAT
• 1½ hours from extraction/messenger arrival

0.00~0.50 ug/mL

• High doses of biotin ( i.e. >5mg/day) may affect results. Samples should not be taken until at least 8 hours following the last biotin administration.
• High concentrations of lipoic acid may yield lower measurement values.
• High concentrations of d-fragments as may appear under thrombolytic therapy may yield lower measurement values.

Not Applicable

Deep vein thrombosis (DVT) ,Pulmonary embolism (PE), Fibrin Degradation Fragment, Fibrin Degradation Products, FDP, PT and INR, PTT, Fibrinogen, Platelet Count

•Dengue Blot

•Dengue Fever Antibodies

• Dengue IgG
• Dengue IgM
 

• Used for the detection of IgG and IgM to dengue virus to human serum or plasma
• Used as an aid in the presumptive diagnosis between primary and secondary dengue infection
• During primary infection, Dengue IgM antibodies may be detectable on the 3rd to 5th day of fever and may persist for 30-60 days. Dengue IgG antibodies may be detected during 14th day of fever and may persist for life.
• In Secondary infections, IgG rises within 1-2 days after the onset of symptoms and induce IgM response after 20 days of infection.

Solid Phase Immunochromatography

Serology

No patient preparation necessary.

NOTE: It is recommended to test for both Dengue NS1 and Dengue IgG/IgM if patient is on the 3rd day and onwards after the onset of fever.

Red or Gold tube

1-2mL Serum

1-2mL Plasma (EDTA, Heparin, Na Citrate)

Not Specified

7 Days

>2 Weeks

Transport specimen at 2 – 10 °C (with cold packs)

• Contaminated and markedly lipemic serum
• Improperly labeled specimens
• Hemolyzed specimens
• Quantity not sufficient
• Specimen stored exceeded outside required stability

Daily

Monday to Saturday
• 8:00 PM

Sunday
• 3:00 PM

ROUTINE
• 3 hours after receipt of specimen/ arrival of messenger
STAT
• 1½ hours from extraction/messenger arrival

• Dengue IgG: NEGATIVE
• Dengue IgM: NEGATIVE

• Serological cross-reactivity across the Flavivirus group (Dengue virus, St. Louis encephalitis, Japanese encephalitis, West Nile virus and Yellow fever virus) is common.
• A negative result does not preclude the possibility of an early infection of Dengue virus.

Not Applicable

Dengue fever; Breakbone fever, Dengue Fever Antibodies; Dengue Fever Virus, Dengue NS Antigen, Dengue Virus by PCR

• Dengue NS1 Antigen

• Dengue NS1

•Dengue Fever Virus

Not Applicable

• Used for the qualitative detection of acute phase of dengue infection
• NS1 antigen may be found in the sample of infected patients from the first day and up to the 5th day after the onset of fever.

Lateral Flow Immunochromatography

Serology

No patient preparation necessary.

NOTE: It is recommended to test for both Dengue NS1 and Dengue IgG/IgM if patient is on the 3rd day and onwards after the onset of fever.

Red or Gold tube

1-2mL Serum

1-2mL Plasma (EDTA, Heparin, Na Citrate)

Not Specified

7 Days

>7 Days

Transport specimen at 2 – 10 °C (with cold packs)

• Contaminated and markedly lipemic serum
• Improperly labeled specimens
• Hemolyzed specimens
• Quantity not sufficient
• Specimen stored exceeded outside required stability

Daily

Monday to Saturday
• 8:00 PM

Sunday
• 3:00 PM

ROUTINE
• 3 hours after receipt of specimen/ arrival of messenger
STAT
• 1½ hours from extraction/messenger arrival

NEGATIVE

Samples from pregnant women or rheumatoid factors or anti-nuclear antibodies may yield positive results. A negative test result cannot exclude a recent infection.

Not Applicable

Dengue fever, Breakbone fever, Dengue Fever Antibodies; Dengue Fever Virus, Dengue Antibodies (IgG, IgM); Dengue Virus by PCR

Dengue Virus RNA Qualitative

Dengue Virus 1 or 3 RNA

Dengue Virus 2 or 4 RNA

Dengue Virus RNA, Qualitative, Real-Time PCR - PCR is used to diagnose Dengue fever infection during the initial stage of infection, days 1-5 after onset of symptoms. The assay has been designed to detect dengue virus subgroups 1 and 3 (DV1/3 probe), as well as subgroups 2 and 4 (DV2/4 probe).

Real-Time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)

Special Test

No patient preparation necessary

Gold or Red tube

3mL Serum

Not Applicable

48 Hours

7 Days

30 Days

Transport specimen at 2°C – 8 °C (with cold packs)

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Batch running

Monday, 12:00 PM

2 weeks after cut-off (excluding saturdays, Sundays and Holidays)

Available upon request

• DPD
• Cross links
• Lysyl Pyridinum
• Pyridinolines
• DeoxyPyridinDinolin - Urine
•  

Not Applicable

There are two major cross linking molecules-pyridinoline and deoxypyridinoline (DPD) which play a role in determining the characteristics of collagen.

Enzyme Immunoassay (EIA)

Special Test

No patient preparation necessary.

Leak proof clean container

100 mL Random Urine

Not Applicable

24 Hours

5 Days

28 Days

Transport specimen at 2 – 8 °C (with cold packs)

• Quality Not Sufficient
• Received room temperature
• Improperly labeled specimen
• Improper urine collection

Batch Running

Friday, 12:00 PM

4 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Not Applicable

None Specified

Not Applicable

Estrogen deficiency, diseases that have high bone turnover rates